Evidence map›Paper›PMID 42499630›Full record

ArticleHealth care science2026

Development and Deployment of DeepSeek-Based Applications in Healthcare: A Chinese Perspective.

Maoxin Lv, Ning Li, Hui Zhang, Chao Liu, Ge Wu, Zheng Zhu, Yao Zhu, Mengchun Gong

Abstract read
In one paragraph

Article in Health care science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maoxin LvDepartment of Urology, First Affiliated Hospital Kunming Medical University Kunming China.ORCID https://orcid.org/0009-0007-5992-9091
Ning LiSchool of Biomedical Engineering Guangdong Medical University Dongguan China.
Hui ZhangPeking Union Medical College Hospital Chinese Academy of Medical Science and Peking Union Medical College Beijing China.
Chao LiuDigital Health China Technologies Co. Ltd. Beijing China.
Ge WuDigital Health China Technologies Co. Ltd. Beijing China.ORCID https://orcid.org/0000-0002-8971-1911
Zheng ZhuDepartment of Urology Xijing Hospital of Air Force Military Medical University Xi'an China.
Yao ZhuDepartment of Urology Fudan University Shanghai Cancer Center Shanghai China.
Mengchun GongGMC Lab, School of Biomedical Engineering, School of Biomedical Engineering Guangdong Medical University Dongguan China.ORCID https://orcid.org/0000-0001-8197-6643

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Artificial intelligence (AI) is already showing enormous potential in the healthcare sector. Generative AI, particularly, is accelerating the sector's digital transformation by delivering intelligent decision support, automated diagnosis, and optimized resource allocation. DeepSeek-R1, a large-language model with a strong performance-to-cost ratio, has gained popularity as a foundation model in Chinese hospitals. However, the deployment of generative AI remains challenging, and hospitals continue to lack clear guidance on how to select among deployment architectures and how to balance computational demand with cost. Deeper, data-driven analysis is therefore warranted to inform future roll-outs. Methods: This study surveyed AI deployment across Chinese hospitals, with a focus on DeepSeek's potential applications under national policies. Data were collected from the top 20 hospitals, regional centers, and township hospitals via official WeChat platforms. The survey examined deployment strategies, model versions, and platform choices, while keeping in account hospital needs, data resources, and technological-economic decisions. Results: The study highlights DeepSeek's impact on diagnostic accuracy, personalized treatment, medical documentation automation, and resource management optimization. Among the 17 surveyed hospitals, 6 hospitals employed detailed model versions, 5 used the 671B model, and 1 used the 32B version. Among 10 hospitals of different levels, 2 selected the 671B, 3 selected the 70B, and 4 selected the 32B model. All hospitals preferred local deployment. Different needs and applications were observed across the studied hospitals. Conclusions: Selection of the right AI model requires balancing computational power with cost. Larger models offer higher accuracy, but incur higher costs, whereas distilled models suit smaller hospitals with fewer resources. Future development should therefore focus on selecting deployment strategies based on the hospital size while addressing data quality disparities to bridge the regional healthcare gaps. As such, coordination among government, hospitals, and doctors is crucial for supporting smarter healthcare transitions.

Indexed as

application of artificial intelligence in healthcareartificial intelligencedeepseek modelhealthcare resource equity

Identifiers

PMID42499630
PMCPMC13398553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.